Ranch Capital Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.68M Buy
26,374
+1,443
+6% +$202K 1.33% 24
2025
Q4
$3.06M Buy
24,931
+1,215
+5% +$148K 1.13% 30
2025
Q3
$2.63M Buy
23,716
+1,351
+6% +$154K 1.02% 31
2025
Q2
$2.48M Buy
22,365
+1,323
+6% +$141K 1.08% 29
2025
Q1
$2.36M Buy
21,042
+1,487
+8% +$153K 1.12% 26
2024
Q4
$1.81M Buy
19,555
+7,153
+58% +$644K 0.85% 37
2024
Q3
$1.04M Buy
12,402
+897
+8% +$68.4K 0.49% 63
2024
Q2
$789K Buy
11,505
+74
+0.6% +$4.94K 0.41% 68
2024
Q1
$837K Buy
11,431
+215
+2% +$16.5K 0.45% 64
2023
Q4
$909K Sell
11,216
-4,489
-29% -$349K 0.57% 59
2023
Q3
$1.18M Buy
15,705
+341
+2% +$26.2K 0.82% 36
2023
Q2
$1.18M Sell
15,364
-76
-0.5% -$6.06K 0.83% 35
2023
Q1
$1.28M Buy
15,440
+495
+3% +$41K 0.94% 30
2022
Q4
$1.28M Sell
14,945
-4,098
-22% -$325K 1% 28
2022
Q3
$1.18M Buy
19,043
+330
+2% +$20.8K 0.96% 31
2022
Q2
$1.16M Buy
18,713
+2,136
+13% +$132K 0.89% 34
2022
Q1
$986K Buy
16,577
+6,193
+60% +$396K 0.65% 47
2021
Q4
$754K Buy
10,384
+150
+1% +$10.3K 0.49% 65
2021
Q3
$715K Buy
10,234
+9,931
+3,278% +$698K 0.45% 64
2021
Q2
$20K Sell
303
-67
-18% -$4.47K 0.01% 488
2021
Q1
$23K Sell
370
-252
-41% -$16.2K 0.02% 439
2020
Q4
$36K Buy
622
+4
+0.6% +$241 0.03% 341
2020
Q3
$39K Buy
618
+3
+0.5% +$208 0.03% 329
2020
Q2
$42K Sell
615
-1,684
-73% -$129K 0.03% 330
2020
Q1
$171K Buy
2,299
+1,652
+255% +$114K 0.17% 131
2019
Q4
$42K Buy
+647
New +$42.1K 0.03% 366

Other funds holding GILD

Ranch Capital Advisors's GILD Position: Q1 2026 in Review

Ranch Capital Advisors increased its Gilead Sciences (GILD) stake by 5.8% in Q1 2026, buying an estimated $202K and bringing the position to 26,374 shares worth $3.68M. The position accounts for 1.33% of the portfolio, ranked #24.

Ranch Capital Advisors first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Ranch Capital Advisors held 26,374 shares of Gilead Sciences worth $3.68M as of Q1 2026.
  • Ranch Capital Advisors bought 1,443 Gilead Sciences shares in Q1 2026, an estimated $202K.
  • Gilead Sciences made up 1.33% of Ranch Capital Advisors's portfolio in Q1 2026, its #24 holding.
  • Ranch Capital Advisors first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Ranch Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.